SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): February 8, 1999
CVS CORPORATION
(exact name of registrant as specified in its charter)
DELAWARE 1-1011 05-0494040
(State of Incorporation) (Commission File No.) (IRS Employer Identification No.)
One CVS Drive
Woonsocket, Rhode Island 02895
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code:
(401) 765-1500
NOT APPLICABLE
(Former Name or Former Address, if changed since last report)
Item 7. Financial Statements and Exhibits
c. Exhibits
99.1 Press release dated February 8, 1999
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CVS CORPORATION
Date: February 8, 1999 By /s/ Philip C. Galbo
-------------------------------------
Philip C. Galbo
Senior Vice President and Treasurer
Exhibit 99.1
Investor Contact: Nancy Christal Media Contact: Fred McGrail
CVS Corporation CVS/pharmacy
914-722-4704 401-765-1500 x 4630
CVS CORPORATION ANNOUNCES PRICING OF $300 MILLION PRIVATE PLACEMENT
WOONSOCKET, RI, February 8, 1999 -- CVS Corporation (NYSE:CVS)
announced today that it privately placed $300 million of 5.50% notes due 2004,
with an original issue price of 99.632%. Closing on the private placement is
expected to occur on or about February 11, 1999. The proceeds from the sale
of the notes will be used to repay outstanding short-term commercial paper.
The notes have not been registered under the Securities Act and
may not be sold absent registration or an applicable exemption from
registration requirements.
